Astellas Pharma Inc (OTCPK:ALPMY)
$ 9.64 0.16 (1.69%) Market Cap: 17.29 Bil Enterprise Value: 21.05 Bil PE Ratio: 0 PB Ratio: 1.80 GF Score: 75/100

Full Year 2020 Astellas Pharma Inc Earnings Call Transcript

May 18, 2020 / 02:00AM GMT
Release Date Price: $16.28 (+0.68%)
Kenji Yasukawa
Astellas Pharma Inc. - President, CEO & Representative Director

[Interpreted] Yasukawa speaking. Good morning. Thank you very much for participating in our financial presentation for FY 2019. As was explained, please regard to early documents while you listen to my presentation. I will mention the page number during my presentation.

Please turn to Page 2. This is a cautionary statement regarding forward-looking information as usual, so I'd like to skip.

Page 3. Before going into the contents of the results, let me explain our efforts against the spread of COVID-19. Stable supply of drugs, quality control, compliance with rules and regulations, safety management and information provision must be continued. To do so under the business continuity plan, those instructed by the company are continuing to carry out our essential business under strict measures to prevent infections. In principle, we are refraining from sales activities. In all regions globally, we continue to provide and gather necessary information in accordance with the rules of each medical institution.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot